Click Here for 5% Off Your First Aladdin Purchase!

JQEZ5 - 97%, high purity , CAS No.1913252-04-6, Inhibitor of enhancer of zeste 2 polycomb repressive complex 2 subunit

  • Moligand™
  • ≥97%
Item Number
J288565
Grouped product items
SKUSizeAvailabilityPrice Qty
J288565-5mg
5mg
In stock
$225.90
J288565-10mg
10mg
In stock
$328.90
J288565-25mg
25mg
In stock
$740.90
J288565-50mg
50mg
In stock
$1,239.90
J288565-100mg
100mg
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$2,169.90

Potent and selective SAM-competitive EZH2 inhibitor

Basic Description

SynonymsN-[(1,2-Dihydro-6-methyl-2-oxo-4-propyl-3-pyridinyl)methyl]-1-(1-methylethyl)-6-[6-(4-methyl-1-piperazinyl)-3-pyridinyl]-1H-pyrazolo[3,4-b]pyridine-4-carboxamide
Specifications & Purity97%
Storage TempStore at -20°C
Shipped InIce chest + Ice pads
GradeMoligand™
Action TypeINHIBITOR
Mechanism of actionInhibitor of enhancer of zeste 2 polycomb repressive complex 2 subunit

Associated Targets

EZH2 Tclin Histone-lysine N-methyltransferase EZH2 1 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

Names and Identifiers

IUPAC Name N-[(6-methyl-2-oxo-4-propyl-1H-pyridin-3-yl)methyl]-6-[6-(4-methylpiperazin-1-yl)pyridin-3-yl]-1-propan-2-ylpyrazolo[3,4-b]pyridine-4-carboxamide
INCHI InChI=1S/C30H38N8O2/c1-6-7-21-14-20(4)34-30(40)24(21)17-32-29(39)23-15-26(35-28-25(23)18-33-38(28)19(2)3)22-8-9-27(31-16-22)37-12-10-36(5)11-13-37/h8-9,14-16,18-19H,6-7,10-13,17H2,1-5H3,(H,32,39)(H,34,40)
InChi Key LQTWDAYNGMMHLV-UHFFFAOYSA-N
Canonical SMILES CCCC1=C(C(=O)NC(=C1)C)CNC(=O)C2=CC(=NC3=C2C=NN3C(C)C)C4=CN=C(C=C4)N5CCN(CC5)C
Isomeric SMILES CCCC1=C(C(=O)NC(=C1)C)CNC(=O)C2=CC(=NC3=C2C=NN3C(C)C)C4=CN=C(C=C4)N5CCN(CC5)C
PubChem CID 121322599
Molecular Weight 542.69

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section

5 results found

Lot NumberCertificate TypeDateItem
C2210618Certificate of AnalysisJan 07, 2022 J288565
C2210661Certificate of AnalysisJan 07, 2022 J288565
C2210662Certificate of AnalysisJan 07, 2022 J288565
C2210678Certificate of AnalysisJan 07, 2022 J288565
C2210682Certificate of AnalysisJan 07, 2022 J288565

Chemical and Physical Properties

SolubilitySolvent:DMSO, Max Conc. mg/mL: 10.85, Max Conc. mM: 20

Safety and Hazards(GHS)

Pictogram(s) GHS07
Signal Warning
Hazard Statements

H315:Causes skin irritation

H319:Causes serious eye irritation

H335:May cause respiratory irritation

Precautionary Statements

P261:Avoid breathing dust/fume/gas/mist/vapors/spray.

P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do - continue rinsing.

Related Documents

References

1. Souroullas GP, Jeck WR, Parker JS, Simon JM, Liu JY, Paulk J, Xiong J, Clark KS, Fedoriw Y, Qi J et al..  (2016)  An oncogenic Ezh2 mutation induces tumors through global redistribution of histone 3 lysine 27 trimethylation..  Nat Med,  22  (6): (632-40).  [PMID:27135738]
2. Zhang H, Qi J, Reyes JM, Li L, Rao PK, Li F, Lin CY, Perry JA, Lawlor MA, Federation A et al..  (2016)  Oncogenic Deregulation of EZH2 as an Opportunity for Targeted Therapy in Lung Cancer..  Cancer Discov,  (9): (1006-21).  [PMID:27312177]

Solution Calculators